Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Vitamin C with metabolites reduce oxalate levels compared to ascorbic acid: a preliminary and novel clinical urologic finding.

Moyad MA, Combs MA, Crowley DC, Baisley JE, Sharma P, Vrablic AS, Evans M.

Urol Nurs. 2009 Mar-Apr;29(2):95-102.

PMID:
19507407
2.

Intake of vitamins B6 and C and the risk of kidney stones in women.

Curhan GC, Willett WC, Speizer FE, Stampfer MJ.

J Am Soc Nephrol. 1999 Apr;10(4):840-5.

3.

Safety and tolerance of ester-C compared with regular ascorbic acid.

Gruenwald J, Graubaum HJ, Busch R, Bentley C.

Adv Ther. 2006 Jan-Feb;23(1):171-8.

PMID:
16644619
4.

A randomized, controlled trial of lactic acid bacteria for idiopathic hyperoxaluria.

Goldfarb DS, Modersitzki F, Asplin JR.

Clin J Am Soc Nephrol. 2007 Jul;2(4):745-9. Epub 2007 May 30.

5.

Vitamin C with metabolites: additional analysis suggests favorable changes in oxalate.

Moyad MA, Combs MA, Baisley JE, Evans M.

Urol Nurs. 2009 Sep-Oct;29(5):383-5.

PMID:
19863045
6.

[Vitamin C and stone risk. Review of the literature].

Traxer O, Pearle MS, Gattegno B, Thibault P.

Prog Urol. 2003 Dec;13(6):1290-4. Review. French.

PMID:
15000301
7.

A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease.

Siva S, Barrack ER, Reddy GP, Thamilselvan V, Thamilselvan S, Menon M, Bhandari M.

BJU Int. 2009 Jan;103(1):18-21. doi: 10.1111/j.1464-410X.2008.08122.x. Epub 2008 Nov 18. Review.

8.

Oxalate metabolism after intestinal bypass operations.

Nordenvall B, Backman L, Larsson L.

Scand J Gastroenterol. 1981 Apr;16(3):395-9.

PMID:
16435482
9.

Determinants of 24-hour urinary oxalate excretion.

Taylor EN, Curhan GC.

Clin J Am Soc Nephrol. 2008 Sep;3(5):1453-60. doi: 10.2215/CJN.01410308. Epub 2008 Jul 23.

10.

Relation of serum ascorbic acid to serum vitamin B12, serum ferritin, and kidney stones in US adults.

Simon JA, Hudes ES.

Arch Intern Med. 1999 Mar 22;159(6):619-24.

PMID:
10090119
11.

Relative hyperoxaluria, crystalluria and haematuria after megadose ingestion of vitamin C.

Auer BL, Auer D, Rodgers AL.

Eur J Clin Invest. 1998 Sep;28(9):695-700.

PMID:
9767367
13.

Oxalate absorption and endogenous oxalate synthesis from ascorbate in calcium oxalate stone formers and non-stone formers.

Chai W, Liebman M, Kynast-Gales S, Massey L.

Am J Kidney Dis. 2004 Dec;44(6):1060-9.

PMID:
15558527
14.

Effects of ascorbic acid and pyridoxine supplementation on oxalate metabolism in peritoneal dialysis patients.

Shah GM, Ross EA, Sabo A, Pichon M, Reynolds RD, Bhagavan H.

Am J Kidney Dis. 1992 Jul;20(1):42-9.

PMID:
1621677
15.

Preventing the common cold with a vitamin C supplement: a double-blind, placebo-controlled survey.

Van Straten M, Josling P.

Adv Ther. 2002 May-Jun;19(3):151-9.

PMID:
12201356
16.

Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.

Zerwekh JE, Odvina CV, Wuermser LA, Pak CY.

J Urol. 2007 Jun;177(6):2179-84.

PMID:
17509313
18.

Ascorbic acid and atherosclerotic cardiovascular disease.

Lynch SM, Gaziano JM, Frei B.

Subcell Biochem. 1996;25:331-67. Review.

PMID:
8821982
19.

[Hyperoxaluria and renal calculi].

Buño Soto A, Torres Jiménez R, García Puig J, Mateos Antón F.

Arch Esp Urol. 1996 Sep;49(7):707-26. Review. Spanish.

PMID:
9020008
20.

Vitamin C metabolites, independent of smoking status, significantly enhance leukocyte, but not plasma ascorbate concentrations.

Moyad MA, Combs MA, Vrablic AS, Velasquez J, Turner B, Bernal S.

Adv Ther. 2008 Oct;25(10):995-1009. doi: 10.1007/s12325-008-0106-y.

PMID:
18836692

Supplemental Content

Support Center